Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by ...

CVS Health (CVS) stock gained as Barclays upgraded the company, citing a compelling path to margin recovery in its Medicare ...

The U.S. government announced quality ratings for 2025 Medicare health and prescription drug plans on Thursday, the first ...

Medicare Advantage plans are changing their quality ratings, with the Centers for Medicare & Medicaid Services (CMS) ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...

Discover why TD Cowen sees 35% upside in CVS Health stock, driven by Medicare Advantage improvements and bullish technical ...

Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...

Read More Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by ...

CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.